the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced it is pledging $7.8million to the ‘Fund our Futures’ campaign led by the Global ...
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback